OGN.NYSEOrganon & CO

Form 4: Organon & Co. Executive Kirke Weaver Reports Stock Transactions

Sentiment:

SEC Form 4

📋All filings for Organon & CO
🔒Login to Follow

Kirke Weaver, General Counsel & Corporate Secretary of Organon & Co., reports the vesting and disposal of restricted stock units (RSUs) on March 31, 2024.

Summary

  • On March 31, 2024, Kirke Weaver, General Counsel & Corporate Secretary of Organon & Co., reported transactions involving Organon common stock.
  • These transactions included the vesting of restricted stock units (RSUs) and the subsequent disposal of shares to cover tax obligations.
  • Specifically, 4,294 RSUs vested, converting into common stock, and 1,224 shares were disposed of at a price of $18.8.
  • Additionally, 6,200 RSUs vested, and 1,767 shares were disposed of at $18.8.
  • Finally, 3,125 RSUs vested, and 891 shares were disposed of at $18.8.
  • Following these transactions, Weaver directly owns 28,268 shares of Organon common stock.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions, with no inherent positive or negative implications for the company's performance.

Future Outlook

The remaining RSUs will vest on March 31, 2025, and March 31, 2026, according to the vesting schedules.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of company executives.

Stakeholder Impact

  • The transactions have a minimal impact on shareholders, as they represent a small portion of the total outstanding shares.

Key Dates

DateDescription
03/31/2023One-third of RSUs granted on November 7, 2022, vested.
03/31/2023One-third of RSUs granted on March 31, 2023, vested.
03/31/2024RSUs vested and shares disposed of to cover tax obligations.
03/31/2025Remaining RSUs granted on November 7, 2022, are scheduled to vest.
03/31/2025Remaining RSUs granted on March 31, 2023, are scheduled to vest.
03/31/2026Final installment of RSUs granted on March 31, 2023, are scheduled to vest.
04/03/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.